ABUS Stock News

Popular stocks:

Suncor Energy

TOP Stocks:

Shares of other companies:

TMC the metals company

KLA

Arbutus Biopharma (ABUS) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 8, 2023 (07:58)

Sector: Healthcare

The share price of Arbutus Biopharma Corp. (ABUS) now

Latest session on the 7th of December for

Arbutus Biopharma Corp. is positive

Trading Volume: 402154

Open: 2.06 / High: 2.08 / Low: 2.04

What analysts predict: $4.6

52-week High/Low: $3.145 / $1.69

50/200 Day Moving Average: $1.866 / $2.316

This figure corresponds to the Average Price over the previous 50/200 days. For Arbutus Biopharma stocks, the 50-day moving average is the support level today.

For Arbutus Biopharma stocks, the 200-day moving average is the resistance level today.

Are you interested in Arbutus Biopharma Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Arbutus Biopharma stock price in 2022, 2023, 2024, 2025, 2026. How much will one Arbutus Biopharma share be worth in 2022 - 2026?

When should I take profit in Arbutus Biopharma stock? When should I record a loss on Arbutus Biopharma stock? What are analysts' forecasts for Arbutus Biopharma stock? What is the future of Arbutus Biopharma stock? We forecast Arbutus Biopharma stock performance using neural networks based on historical data on Arbutus Biopharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Arbutus Biopharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Arbutus Biopharma shares. This happens once a day.

Historical and forecast chart of Arbutus Biopharma stock

The chart below shows the historical price of Arbutus Biopharma stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Arbutus Biopharma stock price can be found in the table below.

Long-term forecasts by years.

Arbutus Biopharma Corporation, a biopharmaceutical company, is engaged in the discovery, development and commercialization of a drug for patients with chronic hepatitis B virus (HBV) infection in the United States. Its HBV product portfolio consists of AB-836, a capsid inhibitor that can inhibit HBV replication by preventing the assembly of functional viral capsids; and AB-423, which is undergoing preclinical studies. The company is also developing RNAi preparations that use the RNA interference pathway, which allows a new approach to the treatment of diseases.

Arbutus Biopharma daily forecast for a month

Date	Target	Pes.	Opt.	Vol., %
Dec 10	2.13	2.11	2.17	2.39
Dec 11	2.14	2.09	2.17	3.83
Dec 12	2.14	2.09	2.16	3.65
Dec 13	2.13	2.08	2.18	4.51
Dec 14	2.10	2.08	2.12	2.06
Dec 15	2.10	2.08	2.14	3.03
Dec 16	2.09	2.05	2.10	2.16
Dec 17	2.10	2.06	2.11	2.79
Dec 18	2.12	2.07	2.16	4.33
Dec 19	2.06	2.03	2.11	3.87
Dec 20	2.01	1.97	2.04	3.52
Dec 21	2.02	2.00	2.05	2.67
Dec 22	2.04	2.02	2.08	3.31
Dec 23	2.04	2.01	2.06	2.60
Dec 24	2.08	2.06	2.12	2.85
Dec 25	2.10	2.06	2.14	3.92
Dec 26	2.14	2.10	2.19	4.51
Dec 27	2.20	2.14	2.22	3.44
Dec 28	2.16	2.12	2.20	3.89
Dec 29	2.14	2.09	2.18	4.64
Dec 30	2.12	2.10	2.14	2.21
Dec 31	2.10	2.05	2.14	4.48
Jan 01	2.09	2.05	2.14	4.18
Jan 02	2.08	2.04	2.10	3.21
Jan 03	2.07	2.05	2.09	2.06
Jan 04	2.13	2.10	2.15	2.49
Jan 05	2.10	2.07	2.12	2.06
Jan 06	2.08	2.07	2.10	1.84
Jan 07	2.08	2.04	2.10	3.16
Jan 08	2.03	1.99	2.06	3.36

Arbutus Biopharma Daily Price Targets

Arbutus Biopharma Stock Forecast 12-10-2023.

Forecast target price for 12-10-2023: $2.13.
Positive dynamics for Arbutus Biopharma shares will prevail with possible volatility of 2.331%.
Pessimistic target level: 2.11
Optimistic target level: 2.17

Arbutus Biopharma Stock Forecast 12-11-2023.

Forecast target price for 12-11-2023: $2.14.
Positive dynamics for Arbutus Biopharma shares will prevail with possible volatility of 3.685%.
Pessimistic target level: 2.09
Optimistic target level: 2.17

Arbutus Biopharma Stock Forecast 12-12-2023.

Forecast target price for 12-12-2023: $2.14.
Positive dynamics for Arbutus Biopharma shares will prevail with possible volatility of 3.525%.
Pessimistic target level: 2.09
Optimistic target level: 2.16

Arbutus Biopharma Stock Forecast 12-13-2023.

Forecast target price for 12-13-2023: $2.13.
Negative dynamics for Arbutus Biopharma shares will prevail with possible volatility of 4.319%.
Pessimistic target level: 2.08
Optimistic target level: 2.18

Arbutus Biopharma Stock Forecast 12-14-2023.

Forecast target price for 12-14-2023: $2.10.
Negative dynamics for Arbutus Biopharma shares will prevail with possible volatility of 2.023%.
Pessimistic target level: 2.08
Optimistic target level: 2.12

Arbutus Biopharma Stock Forecast 12-15-2023.

Forecast target price for 12-15-2023: $2.10.
Negative dynamics for Arbutus Biopharma shares will prevail with possible volatility of 2.943%.
Pessimistic target level: 2.08
Optimistic target level: 2.14

ABUS (ABUS) Monthly Stock Prediction for 2022

Month	Target	Pes.	Opt.	Vol., %
Apr.	3.03	2.95	3.19	7.52
May.	3.25	3.18	3.42	7.10
Jun.	3.30	3.23	3.49	7.40
Jul.	3.27	3.13	3.48	9.90
Aug.	2.99	2.82	3.17	10.94
Sep.	2.95	2.75	3.15	12.49
Oct.	2.91	2.72	3.12	12.76
Nov.	2.94	2.81	3.08	8.75
Dec.	3.04	2.83	3.14	9.68

Full forecast for 2022

Arbutus Biopharma forecast for this year

Arbutus Biopharma Stock Prediction for Apr 2022

An uptrend is forecast for this month with an optimal target price of $3.03364. Pessimistic: $2.95. Optimistic: $3.19

Arbutus Biopharma Stock Prediction for May 2022

An uptrend is forecast for this month with an optimal target price of $3.25206. Pessimistic: $3.18. Optimistic: $3.42

Arbutus Biopharma Stock Prediction for Jun 2022

An uptrend is forecast for this month with an optimal target price of $3.29596. Pessimistic: $3.23. Optimistic: $3.49

Arbutus Biopharma Stock Prediction for Jul 2022

An downtrend is forecast for this month with an optimal target price of $3.26927. Pessimistic: $3.13. Optimistic: $3.48

Arbutus Biopharma Stock Prediction for Aug 2022

An downtrend is forecast for this month with an optimal target price of $2.9868. Pessimistic: $2.82. Optimistic: $3.17

Arbutus Biopharma Stock Prediction for Sep 2022

An downtrend is forecast for this month with an optimal target price of $2.94917. Pessimistic: $2.75. Optimistic: $3.15

Arbutus Biopharma Stock Prediction for Oct 2022

An downtrend is forecast for this month with an optimal target price of $2.9067. Pessimistic: $2.72. Optimistic: $3.12

Arbutus Biopharma Stock Prediction for Nov 2022

An uptrend is forecast for this month with an optimal target price of $2.93809. Pessimistic: $2.81. Optimistic: $3.08

Arbutus Biopharma Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $3.04122. Pessimistic: $2.83. Optimistic: $3.14

Arbutus Biopharma (ABUS) Monthly Stock Prediction for 2023

Month	Target	Pes.	Opt.	Vol., %
Jan	3.21	3.14	3.31	5.06
Feb	3.03	2.82	3.22	12.44
Mar	2.96	2.77	3.09	10.09
Apr	3.18	2.99	3.37	11.20
May	3.31	3.08	3.39	9.07
Jun	3.25	3.12	3.35	6.89
Jul	3.14	3.04	3.35	9.13
Aug	3.15	3.07	3.33	7.83
Sep	3.33	3.18	3.56	10.85
Oct	3.34	3.22	3.47	7.20
Nov	3.08	2.87	3.15	8.97
Dec	2.95	2.82	3.02	6.50

Full forecast for 2023

Arbutus Biopharma (ABUS) Monthly Stock Prediction for 2024

Month	Target	Pes.	Opt.	Vol., %
Jan	3.06	2.94	3.20	8.26
Feb	2.81	2.75	2.90	5.23
Mar	2.80	2.71	2.93	7.41
Apr	2.77	2.63	2.96	11.11
May	2.98	2.89	3.09	6.58
Jun	2.85	2.76	2.99	7.80
Jul	2.76	2.57	2.95	12.87
Aug	2.86	2.79	3.05	8.59
Sep	2.90	2.80	3.01	7.11
Oct	2.71	2.58	2.86	9.96
Nov	2.75	2.66	2.85	6.43
Dec	2.70	2.56	2.76	7.47

Full forecast for 2024

Arbutus Biopharma (ABUS) Monthly Stock Prediction for 2025

Month	Target	Pes.	Opt.	Vol., %
Jan	2.86	2.74	3.00	8.59
Feb	2.81	2.72	2.89	6.03
Mar	2.95	2.85	3.14	9.36
Apr	2.81	2.69	3.00	10.46
May	2.73	2.58	2.84	8.94
Jun	2.67	2.61	2.82	7.31
Jul	2.59	2.42	2.65	8.71
Aug	2.37	2.29	2.46	6.94
Sep	2.47	2.36	2.64	10.52
Oct	2.46	2.32	2.58	10.13
Nov	2.43	2.34	2.61	10.33
Dec	2.65	2.46	2.79	11.80

Full forecast for 2025

Arbutus Biopharma (ABUS) Monthly Stock Prediction for 2026

Month	Target	Pes.	Opt.	Vol., %
Jan	2.59	2.40	2.67	9.96
Feb	2.57	2.44	2.74	10.89
Mar	2.73	2.61	2.85	8.30
Apr	2.78	2.73	2.91	6.20
May	2.69	2.51	2.74	8.40
Jun	2.76	2.67	2.84	6.04
Jul	2.80	2.60	2.87	9.55
Aug	2.71	2.65	2.82	6.06
Sep	2.59	2.50	2.75	8.90
Oct	2.51	2.41	2.67	9.49
Nov	2.54	2.42	2.66	9.04
Dec	2.73	2.56	2.86	10.38

Full forecast for 2026

Arbutus Biopharma information and performance

Arbutus Biopharma Address

100-8900 GLENLYON PARKWAY, BURNABY, BC, CA

Market Capitalization: 344 613 000 $

Market capitalization of the Arbutus Biopharma Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ABUS shares in the company outstanding by the market price of one share.

EBITDA: -77 115 000 $

EBITDA of Arbutus Biopharma is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.46

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: -0.217

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 9.28

Enterprise Value (EV) /Revenue

EV To EBITDA: -2.813

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 167695000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Related stocks from Healthcare sector

IO Biotech, Inc. (IOBT)

Convey Holding Parent, Inc. (CNVY)

Aerie Pharmaceuticals, Inc. (AERI)

Magenta Therapeutics, Inc. (MGTA)

Gilead Sciences, Inc. (GILD)

Abbott Laboratories (ABT)

ACADIA Pharmaceuticals Inc. (ACAD)

Calliditas Therapeutics AB (publ) (CALT)

Antares Pharma, Inc. (ATRS)

Castle Biosciences, Inc. (CSTL)

Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.

<img data-src="/images/stock/ABUS.svg" class="img_30 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="img_30" src="/images/stock/ABUS.svg"> Arbutus Biopharma (ABUS) Stock Forecast for 2023 – 2026. Sell or Buy?